graph, echocardiogram, erythrocyte sedimentation, C-reactive protein, thyroid function tests, homocysteine, ENA panel, c3, c4, activated protein C resistance, anti-cardiolipin antibodies (ACA), anti-thrombin III, Factor V Leiden mutation, fibrinogen, lupus anticoagulant (LA), plasminogen, activated partial thromboplastin time, prothrombin time, thrombin time, protein C activity, PR3 ANCA, HIV serology, biochemistry of haemorrhagic cerebrospinal fluid (CSF) taken from the drainage, MTHFR gene mutation, factors V, VIII and XII activity, CSF mycobacterium tuberculosis analysis and culture. Her protein S level was 11% (normal value 60% to 130%). Repeat protein S levels after 3 months were 14%.
The patient's vital signs and electrolyte balance were corrected, and symptomatic medical treatment was applied. Follow-up head CT showed partial resorption of intraventricular haemorrhage, and CSF was clear in drainage. Based on these observations, the drainage tube was removed. Impaired consciousness and orientation defect improved gradually, and the patient was discharged with normal neurological examination findings.
Written informed consent was obtained from the patient who participated in this report.
DISCUSSION
According to the clinical, radiological, and laboratory findings, the diagnosis of the patient was considered PIVH caused by MMS in association with PSD. PIVH, haemorrhage in the ventricular system without a recognisable parenchymal component, is a rare neurological disorder (9) . Moyamoya is defined as a non-atherosclerotic, non-inflammatory, and nonamyloid vasculopathy of unknown aetiology (1, 2) . In adults, the diagnosis of Moyamoya is defined by 3 angiographic criteria, based on the Japanese Ministry of Health and Welfare guidelines. The first one is stenosis or occlusion at the terminal portion of the internal carotid artery (ICA) and/or at the proximal portion of the anterior and/or the middle cerebral arteries. The second one is abnormal vascular networks in the vicinity of occlusive or stenotic lesions in the arterial phase. The third one is that these findings should be presented bilaterally (4) . Vessels of the posterior circulation are rarely involved, as in our case (2, 3) . CA is still the gold standard for the diagnosis of MMD (2, 3). In our patient, the CA revealed stage 3 to 4 Moyamoya disease according to Suzuki and Takaku's angiographic classification (1, 2) (significant ICA narrowing, characteristic puff-of-smoke appearance and development of extra-cranial collaterals), and ruled out vascular malformations. Postpartum cerebral angiopathy, radiation-induced arteritis, and inflammatory angiopathy are important differential diagnoses that may present with cerebral ischaemia and imaging consistent with intracranial vasculopathy mimicking MMD (2, 3) .
Although MMD is most common in Japanese and other Eastern Asian individuals, it has been found in all races with varying age distributions and clinical manifestations. The distribution pattern of age of onset has two peaks, with the larger peak in the first decade and the smaller one in the third and fourth decades. Clinically, the presentation of patients with MMD may include transient ischaemic attacks, ischaemic strokes, haemorrhagic strokes, and seizures. Intracranial haemorrhage is common in adults between the ages of 30-50 with a higher occurrence in females and the most frequent site being intraventricular (1) (2) (3) (4) . In this case report, age, gender, clinical findings and the location of haemorrhage are consistent with previous reports.
Intracranial haemorrhage may occur because of the rupture of saccular aneurysms in the Circle of Willis, resulting in subarachnoid haemorrhage, or because of the rupture of fragile, dilated, and tortuous Moyamoya vessels, yielding intracerebral or IVH (1-3) . Rupture of a perforating artery or microaneurysm located in the ventricular subependyma may be another cause of PIVH (2) . It was demonstrated by two studies conducted with adult patients with MMD that extension with abnormal branches and excessive dilation of the anterior choroidal and/or posterior communicating arteries (PComAs) are predictors for haemorrhagic lesions, especially IVH (10). There had also been specific dilation on left PComA in angiography in our patient.
Bonduel et al. (5) reported that prothrombotic disorders were detected in 4 out of 10 non-Japanese children with Moyamoya. In their series, inherited PSD was found in 1 patient; LA and ACA were detected in the remaining 3 patients. Pro- tein S is a vitamin-K-dependent glycoprotein that inhibits the coagulation cascade and functions as a co-factor of activated protein C. PSD is often associated with venous and arterial thromboembolism, and can possibly be related with ischaemic stroke, especially in young patients. It is interesting that our patient had PIVH but not thrombotic disease. Sporadic PSD presents in pregnancy, oral contraceptive use, liver disease, acute inflammation, vitamin K deficiency, Factor V Leiden mutation, warfarin treatment, nephrotic syndrome, HIV infection, L-asparaginase chemotherapy or acute thromboembolic events. We ruled out sporadic or transient protein S deficiency by obtaining repeat protein S levels after 3 months and with the help of patient history and laboratory findings. There is no known curative treatment for MMD. In the acute phase of ischaemia and haemorrhagic attack, the treatment is symptomatic (2-4). External ventricular drainage was performed on our patient in whom hydrocephaly had developed, and cerebral perfusion pressure was maintained while avoiding hypovolaemia, dehydration, and hypo/hypertension. Oral anticoagulation is recommended if there is isolated PSD because of the possibility of a recurrent thrombosis. However, prophylactic oral anticoagulation is controversial in MMS patients with PSD due to the risk of intracranial haemorrhage (5, 6) . Because of PIVH, we postponed anti-coagulation in the acute stage. After the resorption of haemorrhage, the patient was offered anticoagulation; however, this could not be initiated because of inadequate follow-up caused by the patient's non-compliance.
In conclusion, clinicians should consider that PSD can appear not only in Moyamoya patients presenting with ischaemic symptoms, but also in adult Moyamoya patients presenting with haemorrhage. 
